Publications by authors named "Lora Waybright"

Claim this Profile
S
Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD).
Britney N Lizama, Eloise Keeling, Eunah Cho, Evi M Malagise, Nicole Knezovich, Lora Waybright

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
Martí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, Kristjan Holt, Robert McGeachan, Lora Waybright

Acta Neuropathol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter.
Kelsie M LaBarbera, Yvette I Sheline, Nicholas J Izzo, Carla M Yuede, Lora Waybright

Transl Neurodegener· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Nicholas J Izzo, Carla M Yuede, Kelsie M LaBarbera, Colleen S Limegrover, Courtney Rehak, Lora Waybright

Alzheimers Dement· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the mature CNS: A predictive screening platform for neurodegenerative disease drug discovery.
Kelsie Mozzoni LaBarbera, Colleen Limegrover, Courtney Rehak, Raymond Yurko, Nicholas John Izzo, Lora Waybright

J Neurosci Methods· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis